How to perform the one-step conservative surgery for placenta accreta spectrum move by move.


Journal

American journal of obstetrics & gynecology MFM
ISSN: 2589-9333
Titre abrégé: Am J Obstet Gynecol MFM
Pays: United States
ID NLM: 101746609

Informations de publication

Date de publication:
02 2023
Historique:
received: 02 09 2022
revised: 01 11 2022
accepted: 05 11 2022
pubmed: 14 11 2022
medline: 14 2 2023
entrez: 13 11 2022
Statut: ppublish

Résumé

There are 3 treatment options for placenta accreta spectrum: cesarean delivery with hysterectomy, expectant management, and uterine-sparing surgical techniques. One-step conservative surgery is the most extensively described conservative surgical technique, and it has extensive evidence supporting its usefulness; however, few groups apply it, most likely because of the misconception that it is a complex procedure that requires extensive training and is applicable to only a few patients. This study aimed to evaluate the clinical outcomes of patients undergoing one-step conservative surgery in 4 placenta accreta spectrum reference hospitals and provided detailed steps for successfully applying this type of surgery. This was a multicenter, descriptive, prospective study that described the outcomes of patients with placenta accreta spectrum treated in 4 reference hospitals for this condition. The patients were divided into those managed with one-step conservative surgery and those managed with cesarean delivery and hysterectomy. Overall, 75 patients were included. One-step conservative surgery was possible in 85.3% of placenta accreta spectrum cases (64 patients). Intraoperative staging and placenta accreta spectrum topographic classification allowed for the selection of one-step conservative surgery candidates. The clinical outcomes of the 2 groups were similar, except for the frequency of transfusions (81.8% in the cesarean delivery and hysterectomy group vs 67.2% in the one-step conservative surgery group) and vascular interventions (27.3% in the cesarean delivery and hysterectomy group vs 4.7% in the one-step conservative surgery group), which were both higher in patients who underwent hysterectomy. In addition, the operation time was shorter in the one-step conservative surgery group (164.4 minutes vs 216.5 minutes). One-step conservative surgery is a valid procedure in most patients with placenta accreta spectrum. It is an applicable technique even in scenarios with limited resources. However, its safe application requires knowledge of the topographic classification and the application of intraoperative staging.

Sections du résumé

BACKGROUND
There are 3 treatment options for placenta accreta spectrum: cesarean delivery with hysterectomy, expectant management, and uterine-sparing surgical techniques. One-step conservative surgery is the most extensively described conservative surgical technique, and it has extensive evidence supporting its usefulness; however, few groups apply it, most likely because of the misconception that it is a complex procedure that requires extensive training and is applicable to only a few patients.
OBJECTIVE
This study aimed to evaluate the clinical outcomes of patients undergoing one-step conservative surgery in 4 placenta accreta spectrum reference hospitals and provided detailed steps for successfully applying this type of surgery.
STUDY DESIGN
This was a multicenter, descriptive, prospective study that described the outcomes of patients with placenta accreta spectrum treated in 4 reference hospitals for this condition. The patients were divided into those managed with one-step conservative surgery and those managed with cesarean delivery and hysterectomy.
RESULTS
Overall, 75 patients were included. One-step conservative surgery was possible in 85.3% of placenta accreta spectrum cases (64 patients). Intraoperative staging and placenta accreta spectrum topographic classification allowed for the selection of one-step conservative surgery candidates. The clinical outcomes of the 2 groups were similar, except for the frequency of transfusions (81.8% in the cesarean delivery and hysterectomy group vs 67.2% in the one-step conservative surgery group) and vascular interventions (27.3% in the cesarean delivery and hysterectomy group vs 4.7% in the one-step conservative surgery group), which were both higher in patients who underwent hysterectomy. In addition, the operation time was shorter in the one-step conservative surgery group (164.4 minutes vs 216.5 minutes).
CONCLUSION
One-step conservative surgery is a valid procedure in most patients with placenta accreta spectrum. It is an applicable technique even in scenarios with limited resources. However, its safe application requires knowledge of the topographic classification and the application of intraoperative staging.

Identifiants

pubmed: 36372188
pii: S2589-9333(22)00232-4
doi: 10.1016/j.ajogmf.2022.100802
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100802

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Albaro José Nieto-Calvache (AJ)

Clínica de Espectro de Acretismo Placentario, Fundación Valle del Lili, Cali, Colombia (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa); Latin American Group for the Study of Placenta Accreta Spectrum (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa). Electronic address: albaro.nieto@fvl.org.co.

José Miguel Palacios-Jaraquemada (JM)

Otamendi Hospital, Buenos Aires, Argentina (Dr Palacios-Jaraquemada).

Rozi Aryananda (R)

Dr. Soetomo Academic General Hospital, Universitas Airlangga, Surabaya, Indonesia (Dr Aryananda).

Nicolas Basanta (N)

Hospital General de Agudos Dr. Juan A. Fernández, Buenos Aires, Argentina (Dr. Nicolas Basanta).

Rudy Aguilera (R)

Hospital De La Mujer Dr. Percy Boland, Santa Cruz de la Sierra, Bolivia (Dr. Rudy Aguilera).

Juan Pablo Benavides (JP)

Clínica de Espectro de Acretismo Placentario, Fundación Valle del Lili, Cali, Colombia (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa); Latin American Group for the Study of Placenta Accreta Spectrum (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa).

Jaime López (J)

Clínica de Espectro de Acretismo Placentario, Fundación Valle del Lili, Cali, Colombia (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa); Latin American Group for the Study of Placenta Accreta Spectrum (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa).

Clara Campos (C)

Clínica de Espectro de Acretismo Placentario, Fundación Valle del Lili, Cali, Colombia (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa); Latin American Group for the Study of Placenta Accreta Spectrum (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa).

Luisa Valencia (L)

Clínica de Espectro de Acretismo Placentario, Fundación Valle del Lili, Cali, Colombia (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa); Latin American Group for the Study of Placenta Accreta Spectrum (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa).

Kevin Arboleda (K)

Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia (Dr. Kevin Arboleda, Dr. Valentina Cabrera, Dr. Jesus Cabrera, and Dr Maya).

Valentina Cabrera (V)

Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia (Dr. Kevin Arboleda, Dr. Valentina Cabrera, Dr. Jesus Cabrera, and Dr Maya).

Jesús Cabrera (J)

Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia (Dr. Kevin Arboleda, Dr. Valentina Cabrera, Dr. Jesus Cabrera, and Dr Maya).

Geraldine Minachi Tavera-Martinez (GM)

Centro de Investigaciones Clínicas, Fundación Valle de Lili, Cali, Colombia (Drs Tavera-Martinez and Sinisterra).

Stiven Sinisterra (S)

Centro de Investigaciones Clínicas, Fundación Valle de Lili, Cali, Colombia (Drs Tavera-Martinez and Sinisterra).

Juliana Maya (J)

Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia (Dr. Kevin Arboleda, Dr. Valentina Cabrera, Dr. Jesus Cabrera, and Dr Maya).

Tatiana Peña (T)

Hospital Universitario del Valle "Evaristo Garcia," Cali, Colombia (Dr Peña).

Juan Manuel Burgos-Luna (JM)

Clínica de Espectro de Acretismo Placentario, Fundación Valle del Lili, Cali, Colombia (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa); Latin American Group for the Study of Placenta Accreta Spectrum (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa).

Adriana Messa (A)

Clínica de Espectro de Acretismo Placentario, Fundación Valle del Lili, Cali, Colombia (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa); Latin American Group for the Study of Placenta Accreta Spectrum (Drs Nieto-Calvache, Benavides, López, Campos, Valencia, Burgos-Luna, and Messa).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH